Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Wockhardt Limited
WARNING LETTER
•Wockhardt Limited•March 22, 2013

Wockhardt Limited – FDA Warning Letter, Mar 22, 2013

Record Details

This FDA Warning Letter, dated July 18, 2013, addresses Wockhardt Limited's pharmaceutical manufacturing facility in Aurangabad, India, following an inspection from March 18-22, 2013. The FDA identified significant violations of current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211) and documented that the firm withheld truthful information, and delayed and limited the inspection. These violations render drug products adulterated under Sections 501(a)(2)(B) and 501(j) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. **Repeatedly delaying, denying, or limiting inspection:** Examples include a QA Officer providing incomplete raw data records, a QC Analyst dumping vial contents to prevent observation, a Production Head providing inaccurate information about unofficial batch records, the Vice President of Manufacturing misrepresenting the operational status of an aseptic filling line, and delaying provision of requested QC data until the inspection's final day. 2. **Failure to prepare complete batch production and control records (21 CFR 211.188(b)):** Unofficial, torn batch records for injectable products showed defect rates exceeding specifications (up to 14%), which should have triggered investigations, but none were performed. Official records for these batches falsely stated compliance. 3. **Failure to ensure laboratory records included complete

Company
Wockhardt Limited
Inspection date
March 22, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michael D. Smedley
View Company Profile

ID · 385b9219-c792-4c20-8952-689016d04159

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.188(b)21 CFR 211.194(a)21 CFR 211.160(a)21 CFR 211.25(a)21 CFR 211.5221 U.S.C. 351(j)21 U.S.C. 356C(a)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Wockhardt Limited
  • WARNING_LETTER - 2013-07-31July 31, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wockhardt Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.